New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes, Rheumatology, vol.47, issue.3, pp.309-310, 2008. ,
DOI : 10.1093/rheumatology/kem318
Cryopyrinopathies: update on pathogenesis and treatment, Nature Clinical Practice Rheumatology, vol.105, issue.9, pp.481-489, 2008. ,
DOI : 10.4049/jimmunol.175.4.2630
Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome, Rheumatol Oxf Engl, vol.55, pp.689-696, 2016. ,
Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.495-499, 2011. ,
DOI : 10.1136/ard.2010.138420
Analysis of Cryopyrin-Associated Periodic Syndromes (CAPS) in German Children: Epidemiological, Clinical and Genetic Characteristics, Klinische P??diatrie, vol.222, issue.06, pp.356-361, 2010. ,
DOI : 10.1055/s-0030-1265181
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry, Annals of the Rheumatic Diseases, vol.15, issue.11, pp.2043-2049, 2015. ,
DOI : 10.1186/ar4171
Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement, Journal of Cutaneous Pathology, vol.18, issue.2, pp.202-208, 2011. ,
DOI : 10.1002/ajmg.a.31148
Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS), Orphanet Journal of Rare Diseases, vol.41, issue.8, p.33, 2017. ,
DOI : 10.3899/jrheum.131291
Neurology of the cryopyrin-associated periodic fever syndrome, European Journal of Neurology, vol.355, issue.7, pp.1145-1151, 2016. ,
DOI : 10.1056/NEJMoa055137
Familial cold autoinflammatory syndrome: Phenotype and genotype of an autosomal dominant periodic fever, Journal of Allergy and Clinical Immunology, vol.108, issue.4, pp.615-620, 2001. ,
DOI : 10.1067/mai.2001.118790
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321996
Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives, Current Medical Research and Opinion, vol.24, issue.6, pp.1577-1582, 2008. ,
DOI : 10.1185/03007990802081543
First report of keratitis in familial cold autoinflammatory syndrome, Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol.49, issue.3, pp.304-306, 2014. ,
DOI : 10.1016/j.jcjo.2014.01.007
[Fever from the cold--familial cold autoinflammatory syndrome], Duodecim Laaketieteellinen Aikakauskirja, vol.125, pp.542-545, 2009. ,
Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist Hereditary periodic fever and reactive amyloidosis, Am J Kidney Dis Off J Natl Kidney Found Clin Exp Med, vol.495, pp.477-48187, 2005. ,
Association of mutations in theNALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis, Arthritis & Rheumatism, vol.46, issue.9, pp.2445-2452, 2002. ,
DOI : 10.1002/art.10509
The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes, Immunology and Allergy Clinics of North America, vol.24, issue.2, pp.259-286, 2004. ,
DOI : 10.1016/j.iac.2004.01.001
A large kindred with familial cold autoinflammatory syndrome, Annals of Allergy, Asthma & Immunology, vol.90, issue.2, pp.233-237, 2003. ,
DOI : 10.1016/S1081-1206(10)62147-3
A: [Syndrome of Muckle-Wells and autoinflammatory familiar syndrome induced by cold, Med ClinBarc), vol.136, 2011. ,
Familial atypical cold urticaria: Description of a new hereditary disease, Journal of Allergy and Clinical Immunology, vol.124, issue.6, pp.1245-1250, 2009. ,
DOI : 10.1016/j.jaci.2009.09.035
Familial Atypical Cold Urticaria Localized on the Face: A Case Report, Acta Dermato Venereologica, vol.94, issue.1, pp.88-89, 2014. ,
DOI : 10.2340/00015555-1621
Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome, Q J Med, vol.31, pp.235-248, 1962. ,
gene, identified by evidence of excessive monocyte production of functional interleukin 1?? and rapid response to anakinra, Clinical and Experimental Dermatology, vol.56, issue.8, pp.874-877, 2013. ,
DOI : 10.1002/art.22842
The 'Muckle???Wells' syndrome, British Journal of Dermatology, vol.36, issue.1, pp.87-92, 1979. ,
DOI : 10.1016/0002-9343(67)90167-2
Muckle- Wells syndrome: 4 cases in three generations], Ann Dermatol Venereol, vol.127, pp.822-824, 2000. ,
NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment, Arthritis Research & Therapy, vol.13, issue.6, p.196, 2011. ,
DOI : 10.1002/art.20032
Challenges in Diagnosing Muckle-Wells Syndrome: Identifying Two Distinct Phenotypes, Arthritis Care & Research, vol.50, issue.Suppl, pp.765-772, 2014. ,
DOI : 10.1093/rheumatology/keq324
Hearing loss in Muckle-Wells syndrome, Arthritis & Rheumatism, vol.70, issue.Suppl, pp.824-831, 2013. ,
DOI : 10.1086/340786
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.37810/pdf
Progressive familial hearing loss in Muckle-Wells syndrome, Acta Oto-Laryngologica, vol.101, issue.7, pp.756-762, 2012. ,
DOI : 10.1002/jcb.21216
Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred, British Journal of Dermatology, vol.103, issue.1, pp.99-104, 2004. ,
DOI : 10.1093/qjmed/91.7.489
Muckle-Wells syndrome: Report of six cases with hyperpigmented sclerodermoid skin lesions, International Journal of Dermatology, vol.257, issue.3, pp.239-244, 2006. ,
DOI : 10.1016/S0140-6736(97)24044-4
H syndrome and Muckle???Wells syndrome, Journal of the American Academy of Dermatology, vol.61, issue.2, p.365, 2009. ,
DOI : 10.1016/j.jaad.2009.04.040
Chronic Keratitis with Intrastromal Epithelioid Histiocytes, Cornea, vol.32, issue.4, pp.510-512, 2013. ,
DOI : 10.1097/ICO.0b013e3182784ad3
Muckle???Wells syndrome: another cause of acute anterior uveitis, Eye, vol.70, issue.6 ,
DOI : 10.1038/sj.eye.6702704
An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K, Rheumatology, vol.50, issue.2, pp.419-420, 2011. ,
DOI : 10.1093/rheumatology/keq280
URL : https://academic.oup.com/rheumatology/article-pdf/50/2/419/5049585/keq280.pdf
<i>CIAS1</i> Mutation in a Patient with Overlap between Muckle-Wells and Chronic Infantile Neurological Cutaneous and Articular Syndromes, Dermatology, vol.206, issue.3, pp.257-259, 2003. ,
DOI : 10.1159/000068883
Neutrophil chemotaxis in a patient with neonatal-onset multisystem inflammatory disease and Muckle-Wells syndrome, Annals of Allergy, Asthma & Immunology, vol.95, issue.4, pp.394-399, 2005. ,
DOI : 10.1016/S1081-1206(10)61159-3
Brain multiple sclerosis-like lesions in a patient with Muckle-Wells syndrome, Rheumatology, vol.48, issue.12, pp.1618-1619, 2009. ,
DOI : 10.1093/rheumatology/kep321
Muckle-Wells Syndrome and Male Hypofertility: A Case Series, Seminars in Arthritis and Rheumatism, vol.42, issue.3, pp.327-331, 2012. ,
DOI : 10.1016/j.semarthrit.2012.03.005
Male infertility: Pathogenesis and clinical diagnosis, Best Practice & Research Clinical Endocrinology & Metabolism, vol.25, issue.2, pp.271-285, 2011. ,
DOI : 10.1016/j.beem.2010.08.006
Inflammatory mediators exert toxic effects of oxidative stress on human spermatozoa, Journal of Andrology, vol.28, issue.2, pp.325-333, 2007. ,
DOI : 10.2164/jandrol.106.001149
Cytokine levels in the seminal plasma of infertile males, J Androl, vol.17, pp.158-163, 1996. ,
Muckle???Wells Cryopyrinopathy: Complex Phenotyping and Response to Therapy in a New Multiplex Kindred, Inflammation, vol.42, issue.2, pp.396-401, 2014. ,
DOI : 10.1002/art.37827
Audiometric characteristics of a Dutch family with Muckle-Wells syndrome, Hearing Research, vol.282, issue.1-2, pp.243-251, 2011. ,
DOI : 10.1016/j.heares.2011.07.006
Early detection of sensorineural hearing loss in Muckle-Wells-syndrome, Pediatric Rheumatology, vol.282, issue.1???2, p.43, 2015. ,
DOI : 10.1016/j.heares.2011.07.006
Risk factors for severe Muckle-Wells syndrome, Arthritis & Rheumatism, vol.65, issue.Suppl, pp.3783-3791, 2010. ,
DOI : 10.1136/ard.2005.038091
Periodic fever: From Still's disease to Muckle-Wells syndrome, Reumatol Clin, 2017. ,
Komplikationen im Verlauf eines Muckle-Wells-Syndroms, DMW - Deutsche Medizinische Wochenschrift, vol.117, issue.07, pp.256-260, 19461992. ,
DOI : 10.1055/s-2008-1062305
Amyloid Goiter and Arthhtides After Kidney Transplantation in a Patient with Systemic Amyloidosis and Muckle-Wells Syndrome, American Journal of Clinical Pathology, vol.92, issue.6, pp.821-825, 1989. ,
DOI : 10.1093/ajcp/92.6.821
Successful renal transplantation in Muckle-Wells syndrome treated with anti-IL-1?-monoclonal antibody, NDT Plus, vol.4, pp.404-405, 2011. ,
Renal and thyroid amyloidosis secondary tocryopyrin-associated periodic syndrome(Muckle-Wells syndrome) (NLRP3 mutation), Nefrol Publicacion Of Soc Espanola Nefrol, vol.33, pp.266-271, 2013. ,
Umbria Domínguez S: [Muckle-Wells syndrome associated with idiopathic interstitial pneumopathy], An Med Interna Madr Spain, vol.8, pp.85-86, 19841991. ,
Phenotype, Genotype, and Sustained Response to Anakinra in 22 Patients With Autoinflammatory Disease Associated With CIAS-1/NALP3 Mutations, Archives of Dermatology, vol.142, issue.12, pp.1591-1597, 2006. ,
DOI : 10.1001/archderm.142.12.1591
Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens, Arthritis Research & Therapy, vol.15, issue.3, p.64, 2013. ,
DOI : 10.1002/art.20631
Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome, Arthritis Rheum, vol.63, pp.840-849, 2011. ,
Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation, The Journal of Pediatrics, vol.99, issue.1, pp.79-83, 1981. ,
DOI : 10.1016/S0022-3476(81)80961-4
Neonatal Onset Multisystem Inflammatory Disease, Arthritis & Rheumatism, vol.2, issue.5, pp.668-673, 1983. ,
DOI : 10.1002/art.1780260515
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.1780260515/pdf
ADULT TOXOPLASMOSIS IN ONE FAMILY, Brain, vol.73, issue.3, pp.281-290, 1950. ,
DOI : 10.1093/brain/73.3.281
Successful Management of Cryopyrin-Associated Periodic Syndrome With Canakinumab in Infancy, PEDIATRICS, vol.134, issue.5, pp.1468-1473, 2014. ,
DOI : 10.1542/peds.2013-3185
A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy, Clin Exp Rheumatol, vol.19, pp.103-106, 2001. ,
Chronic Infantile Neurological Cutaneous and Articular/Neonatal Onset Multisystem Inflammatory Disease Syndrome<subtitle>Ocular Manifestations in a Recently Recognized Chronic Inflammatory Disease of Childhood</subtitle>, Archives of Ophthalmology, vol.118, issue.10, pp.1386-1392, 1960. ,
DOI : 10.1001/archopht.118.10.1386
Neonatal treatment of CINCA syndrome, Pediatric Rheumatology, vol.12, issue.1, p.52, 2014. ,
DOI : 10.1016/j.autrev.2012.07.026
URL : https://ped-rheum.biomedcentral.com/track/pdf/10.1186/1546-0096-12-52?site=ped-rheum.biomedcentral.com
Cryopyrinassociated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg, pp.295-302, 2011. ,
DOI : 10.1177/0194599811402296
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407887
Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review, Orphanet Journal of Rare Diseases, vol.34, issue.10, p.167, 2016. ,
DOI : 10.1016/j.clinthera.2012.09.009
URL : https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-016-0542-8?site=ojrd.biomedcentral.com
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS), Annals of the Rheumatic Diseases, vol.76, issue.6, pp.942-947, 2017. ,
DOI : 10.1136/annrheumdis-2016-209686
A practical approach to the diagnosis of autoinflammatory diseases in childhood, Best Practice & Research Clinical Rheumatology, vol.28, issue.2, pp.263-276, 2014. ,
DOI : 10.1016/j.berh.2014.05.005
A genomic view of mosaicism and human disease, Nature Reviews Genetics, vol.158, issue.5, pp.307-320, 2013. ,
DOI : 10.1002/ajmg.a.35726
Parallel sequencing used in detection of mosaic mutations: Comparison with four diagnostic DNA screening techniques, Human Mutation, vol.5, issue.6, pp.1012-1020, 2009. ,
DOI : 10.1002/humu.20980
Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes, The American Journal of Human Genetics, vol.71, issue.1, pp.198-203, 2002. ,
DOI : 10.1086/341357
gene, Arthritis & Rheumatism, vol.50, issue.12, pp.4045-4050, 2004. ,
DOI : 10.1002/art.20033
De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases, Arthritis & Rheumatism, vol.22, issue.12, pp.3340-3348, 2002. ,
DOI : 10.1002/art.10688
mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes, Annals of the Rheumatic Diseases, vol.72, issue.3, pp.603-610, 2015. ,
DOI : 10.1136/annrheumdis-2012-202913
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1?? Inhibition, New England Journal of Medicine, vol.355, issue.6, pp.581-592, 2006. ,
DOI : 10.1056/NEJMoa055137
Somatic Mosaicism of CIAS1 in a Patient with Chronic Infantile Neurologic, Cutaneous, Articular Syndrome, Journal of Allergy and Clinical Immunology, vol.117, issue.2, pp.3579-3585, 2005. ,
DOI : 10.1016/j.jaci.2005.12.074
A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism unde, Arthritis & Rheumatism, vol.338, issue.Suppl, pp.1158-1166, 2010. ,
DOI : 10.1002/art.27342
Separating human DNA mixtures using denaturing high-performance liquid chromatography, Expert Review of Molecular Diagnostics, vol.26, issue.1, pp.53-63, 2005. ,
DOI : 10.1006/abio.1994.1543
mutation in cryopyrin-associated periodic syndromes: Table??1, Annals of the Rheumatic Diseases, vol.72, issue.6, pp.1109-1110, 2013. ,
DOI : 10.1136/annrheumdis-2012-202913
Somatic NOD2 mosaicism in Blau syndrome, Journal of Allergy and Clinical Immunology, vol.136, issue.2, pp.484-487, 2015. ,
DOI : 10.1016/j.jaci.2014.12.1941
Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study, Arthritis & Rheumatology, vol.16, issue.11, pp.3027-3036, 2015. ,
DOI : 10.1002/art.27342
URL : https://hal.archives-ouvertes.fr/hal-01261619
Regulation of the Antimicrobial Response by NLR Proteins, Immunity, vol.34, issue.5, pp.665-679, 2011. ,
DOI : 10.1016/j.immuni.2011.05.007
The Inflammasome, Molecular Cell, vol.10, issue.2, pp.417-426, 2002. ,
DOI : 10.1016/S1097-2765(02)00599-3
Inflammasomes and Their Roles in Health and Disease, Annual Review of Cell and Developmental Biology, vol.28, issue.1, pp.137-161, 2012. ,
DOI : 10.1146/annurev-cellbio-101011-155745
Inflammasomes: current understanding and open questions, Cellular and Molecular Life Sciences, vol.284, issue.5, pp.765-783, 2011. ,
DOI : 10.1074/jbc.M806084200
Intracellular pattern recognition receptors in the host response, Nature, vol.83, issue.7098, pp.39-44, 2006. ,
DOI : 10.4049/jimmunol.175.8.5260
Interleukin-1beta, Interleukin-18, and the Interleukin-1beta Converting Enzymea, Annals of the New York Academy of Sciences, vol.4, issue.1 MOLECULAR MEC, pp.1-11, 1998. ,
DOI : 10.1016/0167-5699(90)90155-3
Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1?? and IL-1??, Proceedings of the National Academy of Sciences, vol.281, issue.11, pp.19449-19454, 2010. ,
DOI : 10.1074/jbc.M512447200
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver, World Journal of Gastroenterology, vol.17, issue.43, pp.4772-4778, 2011. ,
DOI : 10.3748/wjg.v17.i43.4772
A role for mitochondria in NLRP3 inflammasome activation, Nature, vol.14, issue.7329, pp.221-225, 2011. ,
DOI : 10.1038/sj.cdd.4402142
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome, Annals of the Rheumatic Diseases, vol.67, issue.2, pp.278-279, 2008. ,
DOI : 10.1136/ard.2006.068254
Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Beh??et???s disease, Clinical Rheumatology, vol.348, issue.25, pp.209-210, 2010. ,
DOI : 10.1007/s10067-009-1279-8
Resistant Beh??et Disease Responsive to Anakinra, Annals of Internal Medicine, vol.149, issue.4, pp.284-286, 2008. ,
DOI : 10.7326/0003-4819-149-4-200808190-00018
IL-1 Blockade in Autoinflammatory Syndromes, Annual Review of Medicine, vol.65, issue.1, pp.223-244, 2014. ,
DOI : 10.1146/annurev-med-061512-150641
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178953
Interleukin-1???Receptor Antagonist in the Muckle???Wells Syndrome, anakinra on arthropathy in CINCA/NOMID syndrome, pp.2583-25849, 2003. ,
DOI : 10.1056/NEJM200306193482523
Targeting interleukin-1?? in CAPS (cryopyrin-associated periodic) syndromes, Autoimmunity Reviews, vol.12, issue.1, pp.77-80, 2012. ,
DOI : 10.1016/j.autrev.2012.07.026
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome, New England Journal of Medicine, vol.360, issue.23, pp.2416-2425, 2009. ,
DOI : 10.1056/NEJMoa0810787
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes, Annals of the Rheumatic Diseases, vol.70, issue.12, pp.2095-2102, 2011. ,
DOI : 10.1136/ard.2011.152728
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age, Arthritis Research & Therapy, vol.15, issue.1, p.33, 2013. ,
DOI : 10.1002/art.33342
Longterm safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients, Clin Exp Rheumatol, vol.117, p.124, 2016. ,
Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results), Clin Exp Rheumatol, vol.31, pp.302-309, 2013. ,
Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience, Rheumatology, vol.53, issue.4, pp.665-670, 2014. ,
DOI : 10.1093/rheumatology/ket415
Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians, Therapeutic Advances in Musculoskeletal Disease, vol.70, issue.6, pp.315-329, 2013. ,
DOI : 10.1016/j.coi.2008.01.003
Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous, and articular syndrome: a case study, Journal of Ophthalmic Inflammation and Infection, vol.30, issue.1, p.34, 2015. ,
DOI : 10.2177/jsci.30.63
Corneal response to Canakinumab in Cryopyrin associated periodic fever syndrome, British Journal of Ophthalmology, vol.1, issue.8, pp.1081-1082, 2013. ,
DOI : 10.1097/ICO.0b013e3182784ad3
URL : https://eprints.soton.ac.uk/352125/1/Br%2520J%2520Ophthalmol-2013-Tsatsos-1081-2.pdf
Longterm Followup of Quality of Life in Patients with Cryopyrin-associated Periodic Syndrome Treated with Canakinumab, an Anti-interleukin 1?? Monoclonal Antibody, The Journal of Rheumatology, vol.41, issue.8, pp.1721-1722, 2014. ,
DOI : 10.3899/jrheum.131291
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study, Arthritis Care & Research, vol.41, issue.6, pp.903-911, 2017. ,
DOI : 10.3899/jrheum.131291
Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort, Clin Exp Rheumatol, vol.33, pp.67-71, 2015. ,
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome, Arthritis & Rheumatism, vol.58, issue.8, pp.2432-2442, 2008. ,
DOI : 10.4049/jimmunol.175.4.2630
Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies, Arthritis & Rheumatism, vol.365, issue.8, pp.2443-2452, 2008. ,
DOI : 10.1002/art.23687
Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study, Clinical Therapeutics, vol.34, issue.10, pp.2091-2103, 2012. ,
DOI : 10.1016/j.clinthera.2012.09.009
Recommendations for the management of autoinflammatory diseases, Annals of the Rheumatic Diseases, vol.66, issue.(0003???9950 (Print)), pp.1636-1644, 2015. ,
DOI : 10.1002/art.38802
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.414-422, 2011. ,
DOI : 10.1136/ard.2010.137216
in Patients With Cryopyrin-Associated Periodic Syndromes, Arthritis & Rheumatology, vol.202, issue.2, pp.516-520, 2016. ,
DOI : 10.1086/653739
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study, Rheumatology, p.185, 2017. ,
DOI : 10.1093/rheumatology/kex185
One Target???Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1??, Journal of Molecular Biology, vol.425, issue.1, pp.94-111, 2013. ,
DOI : 10.1016/j.jmb.2012.09.021
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases, Frontiers in Pharmacology, vol.47, p.278, 2017. ,
DOI : 10.1002/mc.20437
A novel human anti-interleukin-1?? neutralizing monoclonal antibody showing in vivo efficacy, mAbs, vol.6, issue.3, pp.765-773, 2014. ,
DOI : 10.1038/nprot.2007.173
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases, Nature Medicine, vol.1040, pp.248-255, 2015. ,
DOI : 10.1007/978-1-62703-523-1_2
The ketone metabolite ??-hydroxybutyrate blocks NLRP3 inflammasome???mediated inflammatory disease, Nature Medicine, vol.488, pp.263-269, 2015. ,
DOI : 10.1038/nature11250
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352123
Impact of Peripheral Ketolytic Deficiency on Hepatic Ketogenesis and Gluconeogenesis during the Transition to Birth, Journal of Biological Chemistry, vol.59, issue.27, pp.19739-19749, 2013. ,
DOI : 10.1136/jclinpath-2011-200218
Inflammasome Inhibition: Putting Out the Fire, Cell Metabolism, vol.21, issue.4, pp.513-514, 2015. ,
DOI : 10.1016/j.cmet.2015.03.012
URL : http://doi.org/10.1016/j.cmet.2015.03.012
Regulating against the dysregulation: new treatment options in autoinflammation, Seminars in Immunopathology, vol.43, issue.4, pp.429-437, 2015. ,
DOI : 10.1016/j.arcmed.2012.06.011
High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an international multicenter collaborative study, Arthritis & Rheumatism, vol.9, issue.11, pp.3625-3632, 2011. ,
DOI : 10.1038/gene.2008.66
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU, Blood, vol.103, issue.7, pp.2809-2815, 2004. ,
DOI : 10.1182/blood-2003-07-2531
URL : https://hal.archives-ouvertes.fr/hal-00086300
Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment, European Journal of Haematology, vol.127, issue.3, pp.215-219, 2003. ,
DOI : 10.1016/S0929-693X(99)80006-2
Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients, Blood, vol.111, issue.4, pp.2132-2141, 2008. ,
DOI : 10.1182/blood-2007-06-094201
URL : http://www.bloodjournal.org/content/bloodjournal/111/4/2132.full.pdf
Mosaicism in a Patient With Chronic Infantile Neurologic, Cutaneous, Articular Syndrome, Arthritis & Rheumatology, vol.155, issue.1, pp.197-202, 2014. ,
DOI : 10.1002/ajmg.a.34325
Brief Report, Epidemiology, vol.27, issue.5, pp.2482-2486, 2015. ,
DOI : 10.1097/EDE.0000000000000502
Mosaicism, Arthritis & Rheumatology, vol.5, issue.12, pp.3035-3041, 2016. ,
DOI : 10.1038/nri1707
Myeloid lineage???restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome, Journal of Allergy and Clinical Immunology, vol.135, issue.2, pp.561-564, 2015. ,
DOI : 10.1016/j.jaci.2014.07.050
Mosaicism, Arthritis & Rheumatology, vol.95, issue.4, pp.1039-1044, 2016. ,
DOI : 10.1172/JCI117740
Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis, Orphanet Journal of Rare Diseases, vol.63, issue.11, p.86, 2015. ,
DOI : 10.1002/art.30512
The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1?? and IL-18 Production, PLoS ONE, vol.38, issue.4, p.34977, 2012. ,
DOI : 10.1371/journal.pone.0034977.g003
A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants, Clinical Immunology, vol.157, issue.1, pp.56-64, 2015. ,
DOI : 10.1016/j.clim.2015.01.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597079
Infevers: An evolving mutation database for auto-inflammatory syndromes, Human Mutation, vol.11, issue.3, pp.194-198, 2004. ,
DOI : 10.1002/humu.20080
Deletion, Arthritis & Rheumatology, vol.136, issue.8, pp.2044-2049, 2016. ,
DOI : 10.1016/j.jaci.2014.12.1941
Activated STING in a Vascular and Pulmonary Syndrome, New England Journal of Medicine, vol.371, issue.6, pp.507-518, 2014. ,
DOI : 10.1056/NEJMoa1312625
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174543
JAK inhibition in STING-associated interferonopathy, Annals of the Rheumatic Diseases, vol.75, issue.12, pp.75-124, 2016. ,
DOI : 10.1056/NEJMoa1312625
Schnitzler's syndrome: diagnosis, treatment, and follow-up, Allergy, vol.129, issue.5 Suppl, pp.562-568, 2013. ,
DOI : 10.1016/j.jaci.2011.10.031
URL : http://onlinelibrary.wiley.com/doi/10.1111/all.12129/pdf
Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome, Clinical Rheumatology, vol.54, issue.7, pp.277-279, 2008. ,
DOI : 10.1007/s10067-007-0734-7
Janeway's Immunobiology, 9ième édition, Garland Science, issue.1, p.855, 2016. ,
Comment d??finir et??classer les??maladies inflammatoires?, Revue du Rhumatisme, vol.74, issue.8, pp.714-725, 2007. ,
DOI : 10.1016/j.rhum.2007.07.003
Disponible sur: https://www.vidal.fr/Medicament/ilaris-110375.htm, p.124 ,